Healio

Low-dose colchicine cost-effective in COLCOT trial, over lifetime

Please provide your email address to receive an email when new articles are posted on . A cost analysis of findings from the COLCOT trial showed that the addition of low-dose colchicine therapy to ...
TCTMD

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Low-dose colchicine not only lowers the risk of ischemic CV events post-MI, it also can do so cost-effectively, according to the latest numbers from COLCOT. This is true from the perspective of the ...
Healio

Review: Colchicine helpful in stable CAD, but long-term safety unknown

Please provide your email address to receive an email when new articles are posted on . In the research summary written on behalf of the LoDoCo2 Steering Committee, researchers said the self-assembly ...
Medscape

Colchicine a New Tool for Ischemic Stroke, CVD Event Recurrence?

BASEL, SWITZERLAND — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of the ...